Cover Image

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine

Saved in:

Bibliographic Details
Main Author:	Chun-Bing Chen (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Comprehensive Review of <i>HLA</i> and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
by: Chiraphat Kloypan, et al.
Published: (2021)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
by: Ai-Hoc Nguyen, et al.
Published: (2023)

Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients
by: Gaidganok Sornsamdang, et al.
Published: (2024)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
by: Chih-Jung Chang, et al.
Published: (2020)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022)

Precision dosing to avoid adverse drug reactions
by: Thomas M. Polasek, et al.
Published: (2019)

Cardiovascular precision medicine - A pharmacogenomic perspective
by: Sandosh Padmanabhan, et al.
Published: (2023)

Adverse cutaneous drug reaction
by: Nayak Surajit, et al.
Published: (2008)

Severe Cutaneous Adverse Drug Reaction
by: Damayanti Damayanti, et al.
Published: (2017)

The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review
by: Getahun KA, et al.
Published: (2024)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
by: Gabriela Rossi, et al.
Published: (2021)

Unusual and interesting adverse cutaneous drug reactions
by: Vaishali Masatkar, et al.
Published: (2018)

Controversies in the management of cutaneous adverse drug reactions
by: Yashpal Manchanda, et al.
Published: (2018)

Skin Test for Cutaneous Adverse Drug Reactions
by: Yusuf Wibisono, et al.
Published: (2020)

Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
by: Debleena Guin, et al.
Published: (2019)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
by: Veronique Michaud, et al.
Published: (2021)

Recent advances in severe cutaneous adverse drug reaction
by: Sudip Das, et al.
Published: (2018)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
by: Koraisha Hoosen, et al.
Published: (2019)

Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges
by: Alessia Mondello, et al.
Published: (2024)

Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
by: Debleena Guin, et al.
Published: (2020)

Precision medicine in pharmacy: assessing pharmacogenomics competence among pharmacists and pharmacy students
by: Mohanad Odeh, et al.
Published: (2024)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
by: Chuang-Wei Wang, et al.
Published: (2022)

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
by: Calderon-Ospina CA, et al.
Published: (2020)

HLA-B*58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand
by: Chonlaphat Sukasem, et al.
Published: (2016)

Severe cutaneous adverse drug reactions: A clinicoepidemiological study
by: Sarita Sasidharanpillai, et al.
Published: (2015)

Cutaneous Adverse Drug Reactions in Hospitalized HIV/AIDS Patients
by: Yusuf Wibisono, et al.
Published: (2021)

Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives
by: Kholoud Bastaki, et al.
Published: (2024)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
by: Qiancheng Deng, et al.
Published: (2017)

Cutaneous adverse drug reactions in Indian population: A systematic review
by: Tejas K Patel, et al.
Published: (2014)

Oral antifungal therapy: Emerging culprits of cutaneous adverse drug reactions
by: Raju G Chaudhary, et al.
Published: (2019)

Severe cutaneous adverse reactions to drugs: a case series study
by: Clarisse F. CASTRO, et al.
Published: (2020)

A cross-sectional study of adverse cutaneous drug reactions with special reference to reaction time
by: P Deepthi, et al.
Published: (2022)

A cross-sectional study of adverse cutaneous drug reactions with special reference to reaction time
by: P Deepthi, et al.
Published: (2022)

Cutaneous adverse drug reactions to targeted chemotherapeutic drugs: A clinico-epidemiological study
by: Kriteeka Saini, et al.
Published: (2019)

Clinicoepidemiological Profile of Severe Cutaneous Adverse Drug Reaction: A Retrospective Study
by: Damayanti Damayanti, et al.
Published: (2019)

Analysis of cutaneous adverse drug reactions reported at the regional ADR monitoring center
by: Anal Modi, et al.
Published: (2019)

Clinical profile and comparison of causality assessment tools in cutaneous adverse drug reactions
by: Ranjana Beniwal, et al.
Published: (2019)

The role of frozen section in the rapid diagnosis of severe cutaneous adverse drug reactions
by: Rajam Nicholas, et al.
Published: (2021)

Systems Pharmacology and Network Analysis to Advance Pharmacogenomics and Precision Medicine Decisions in Type-2 Diabetes Therapy
by: Aikaterini Saiti, et al.
Published: (2023)